PP

Piotr P.

Product Owner / Lead Business Analyst / PM In Smart Factory Predictive Operations - Via Toptal at Pfizer

Piotr P. is a seasoned professional with extensive experience in technology consulting, project management, and product ownership. Currently serving as a Product Owner and Lead Business Analyst at Pfizer since July 2022, Piotr is responsible for the full lifecycle of AWS cloud data solutions as part of the Digital Smart Factory Transformation Programme. Previously, from March 2013 to June 2022, Piotr held a managerial role at EY Technology Consulting, focusing on Big Data, Business Intelligence, and Software Quality Assurance across various sectors. Background includes roles such as Analyst at Accenture and Senior Associate Consultant at MicroStrategy, along with freelance web development experience. Piotr holds a Master’s degree in Computer Science from Lodz University of Technology and a Postgraduate degree in Business Administration and Management from SGH Warsaw School of Economics.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Pfizer

606 followers

Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.